In cardiac surgery with a high risk of significant blood loss, aprotinin significantly reduced bleeding, mortality and hospital stay.<ref name=Mahdy/> Beneficial effects were also reported in high-risk orthopedic surgery.<ref name=Mahdy/> In [[liver transplantation]], initial reports of benefit were overshadowed by concerns about toxicity.<ref name=Xia>{{cite journal |vauthors=Xia VW, Steadman RH |title=Antifibrinolytics in orthotopic liver transplantation: current status and controversies |journal=Liver Transpl. |volume=11 |issue=1 |pages=10â€“8 |year=2005 |pmid=15690531 |doi=10.1002/lt.20275}}</ref>
